Drug Delivery to Posterior Segment of the Eye: Conventional Delivery Strategies, Their Barriers, and Restrictions
Authors:
- 9 October 2018
- book chapter
- Published by Springer Nature
- p. 51-67
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokineticsProgress in Retinal and Eye Research, 2010
- Suprachoroidal Drug Delivery to the Back of the Eye Using Hollow MicroneedlesPharmaceutical Research, 2010
- Drug delivery to the posterior segment of the eye for pharmacologic therapyExpert Review of Ophthalmology, 2010
- The Effects of Intravitreal Ophthalmic Medications on Intraocular PressureSeminars in Ophthalmology, 2009
- Trans-scleral Delivery of Antiangiogenic ProteinsJournal of Ocular Pharmacology and Therapeutics, 2008
- Pharmacokinetics of Intraocular Drug Delivery by Periocular Injections Using Ocular FluorophotometryInvestigative Ophthalmology & Visual Science, 2007
- Phase I and Phase II Ocular Metabolic Activities and the Role of Metabolism in Ophthalmic Prodrug and Codrug Design and DeliveryMolecules, 2007
- Bovine and Porcine Transscleral Solute Transport: Influence of Lipophilicity and the Choroid–Bruch’s LayerInvestigative Ophthalmology & Visual Science, 2006
- Permeability of Retinal Pigment Epithelium: Effects of Permeant Molecular Weight and LipophilicityInvestigative Ophthalmology & Visual Science, 2005
- Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrixJournal of Controlled Release, 2003